Mission statement · Company scope
“Our mission is to translate the promise of gene editing into a broad class of differentiated, transformational medicines for previously untreatable diseases.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Impact (primary) · Innovation
- Leads with
- Change
- Best for
- Mission-driven · Climate & health
- Formula
- A world where [change]
- Tone
- Aspirational
- Length
- 22 words · reading grade 17.1
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_b8234e6b36b8c635
- Classification confidence
- 0.57
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-09 · sec_sentence · 10-K · accession 0001650664-26-000017
View filing ↗0 to compareCompare